nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.0671	0.0906	CcSEcCtD
Carboprost Tromethamine—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.051	0.0689	CcSEcCtD
Carboprost Tromethamine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0315	0.0425	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0289	0.039	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0272	0.0367	CcSEcCtD
Carboprost Tromethamine—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0252	0.034	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0249	0.0337	CcSEcCtD
Carboprost Tromethamine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0334	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0215	0.029	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CHRM3—nephrolithiasis	0.0192	0.0738	CbGpPWpGaD
Carboprost Tromethamine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0255	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0238	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0231	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0152	0.0205	CcSEcCtD
Carboprost Tromethamine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0204	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0149	0.0574	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0146	0.0561	CbGpPWpGaD
Carboprost Tromethamine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0188	CcSEcCtD
Carboprost Tromethamine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0186	CcSEcCtD
Carboprost Tromethamine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0185	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0184	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0134	0.018	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0133	0.0513	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.013	0.0502	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0175	CcSEcCtD
Carboprost Tromethamine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0172	CcSEcCtD
Carboprost Tromethamine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0172	CcSEcCtD
Carboprost Tromethamine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0169	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0168	CcSEcCtD
Carboprost Tromethamine—Cough—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0167	CcSEcCtD
Carboprost Tromethamine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0163	CcSEcCtD
Carboprost Tromethamine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0163	CcSEcCtD
Carboprost Tromethamine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.012	0.0162	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0156	CcSEcCtD
Carboprost Tromethamine—Shock—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0154	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0152	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0151	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0108	0.0415	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0105	0.0406	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0142	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.014	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0139	CcSEcCtD
Carboprost Tromethamine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0139	CcSEcCtD
Carboprost Tromethamine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0134	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00963	0.0371	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00942	0.0363	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00914	0.0123	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0115	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00832	0.0321	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0083	0.0112	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00814	0.0314	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0107	CcSEcCtD
Carboprost Tromethamine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00765	0.0103	CcSEcCtD
Carboprost Tromethamine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00993	CcSEcCtD
Carboprost Tromethamine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00729	0.00985	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00984	CcSEcCtD
Carboprost Tromethamine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00724	0.00979	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00713	0.0275	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00698	0.0269	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00687	0.00928	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—RGS14—nephrolithiasis	0.00628	0.0242	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00615	0.0237	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RGS14—nephrolithiasis	0.0057	0.022	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RGS14—nephrolithiasis	0.00558	0.0215	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CHRM3—nephrolithiasis	0.00543	0.0209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00531	0.0205	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTH—nephrolithiasis	0.00497	0.0191	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTH—nephrolithiasis	0.00486	0.0187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DGKH—nephrolithiasis	0.00424	0.0163	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00415	0.016	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADCY10—nephrolithiasis	0.00396	0.0153	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADCY10—nephrolithiasis	0.00388	0.0149	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DGKH—nephrolithiasis	0.00385	0.0148	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DGKH—nephrolithiasis	0.00377	0.0145	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RGS14—nephrolithiasis	0.00337	0.013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RGS14—nephrolithiasis	0.0033	0.0127	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00307	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.003	0.0116	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTH—nephrolithiasis	0.00281	0.0108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CHRM3—nephrolithiasis	0.00279	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTH—nephrolithiasis	0.00275	0.0106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00273	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTH—nephrolithiasis	0.00255	0.00982	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTH—nephrolithiasis	0.00249	0.00961	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00228	0.00877	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DGKH—nephrolithiasis	0.00228	0.00877	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00223	0.00858	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DGKH—nephrolithiasis	0.00223	0.00858	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CHRM3—nephrolithiasis	0.00165	0.00634	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CHRM3—nephrolithiasis	0.00161	0.00621	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTH—nephrolithiasis	0.00151	0.0058	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTH—nephrolithiasis	0.00147	0.00568	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—nephrolithiasis	0.000756	0.00291	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—nephrolithiasis	0.00074	0.00285	CbGpPWpGaD
